Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...

The Trump administration is inching closer to banning fluoride tablets and drops often prescribed to kids who don’t have ...

Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...

SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- Investors in Replimune Group, a biotechnology company focused on cancer treatments, witnessed a dramatic collapse in their holdings on July 22. Shares ...

A timeline of key developments surrounding Sarepta Therapeutics' Duchenne muscular dystrophy drug Elevidys, and the potential ...

Government takes action against 694 firms for drug quality issues after inspecting 905 units, leading to regulatory ...

Inotrem Unveils Game-Changing Precision Medicine Strategy for Nangibotide Clinical Development in Septic Shock ...

Biosimilars could make healthcare more affordable—but here’s why activists are pushing for major revisions and greater ...

Roche is focusing on early diagnosis of Alzheimer's disease and will soon release its first blood-based biomarker for the ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing ...

The Environmental Working Group (EWG) has shed new light on sunscreen safety in the U.S. with a new and eye-opening report.